Clinical Trial Update: Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia [Phase 2]

View source ↗

Summary

Phase 2 trial update for APD125 in patients with sleep maintenance insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• APD125

Snippet

Sponsor: Arena Pharmaceuticals | Conditions: Primary Insomnia | Phase 2 | Status: COMPLETED